CircRNA hsa_circ_0002577 accelerates endometrial cancer progression through activating IGF1R/PI3K/Akt pathway

被引:0
作者
Yu Wang
Lili Yin
Xiaofei Sun
机构
[1] Shengjing Hospital Affiliated to China Medical University,Department of Obstetrics & Gynecology
来源
Journal of Experimental & Clinical Cancer Research | / 39卷
关键词
Circular RNA; Endometrial cancer; IGF1R; miRNA sponge; PI3K/Akt pathway;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 130 条
[1]  
Tran AQ(2017)Recent Advances in Endometrial Cancer F1000Res 6 81-315
[2]  
Gehrig P(2018)Metastatic recurrence after a pT1a grade 1 endometrioid endometrial adenocarcinoma Eur J Gynaecol Oncol 39 314-104
[3]  
Lai-Tiong F(2018)Epidemiology of gynecologic cancers in China J Gynecol Oncol 29 103-29
[4]  
Jiang X(2009)Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium Int J gynaecol Obstet: the official organ of the International Federation of Gynaecology and Obstetrics 105 5-10
[5]  
Tang H(2015)Cancer statistics, 2015. CA Cancer J Clin 65 1-1259
[6]  
Chen T(2014)Surgical treatment for apparent early stage endometrial cancer Obstet Gynecol Sci 57 1250-350
[7]  
Pecorelli S(2016)Chemotherapy for endometrial Cancer in adjuvant and advanced disease settings Oncologist 21 345-3582
[8]  
Siegel RL(2012)Lapatinib and potential prognostic value of EGFR mutations in a gynecologic oncology group phase II trial of persistent or recurrent endometrial cancer Gynecol Oncol 127 3576-388
[9]  
Miller KD(2015)Randomized phase II trial of Ridaforolimus in advanced endometrial carcinoma J Clin Oncol: official journal of the American Society of Clinical Oncology 33 381-9342
[10]  
Jemal A(2015)Regulation of circRNA biogenesis RNA Biol 12 90-197